Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Galactica Pharmaceuticals General Information
Galactica Pharmaceuticals is a platform company focused on developing RAGE fusion protein therapeutics for major diseases including COVID-19, diabetes complications, and macular degeneration. Their lead asset has shown promising preclinical results and they are preparing for clinical trials.
Contact Information
Website
Primary Industry
Biotech
Corporate Office
Villanova, Pennsylvania
USA
USA
Drug Pipeline
RAGE-Fc
INDKey Partnerships
Galactica Pharmaceuticals Funding
No funding data available
To view Galactica Pharmaceuticals's complete valuation and funding history, request access »